188 related articles for article (PubMed ID: 15781835)
21. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
Stefan H; Wang-Tilz Y; Pauli E; Dennhöfer S; Genow A; Kerling F; Lorber B; Fraunberger B; Halboni P; Koebnick C; Gefeller O; Tilz C
Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
[TBL] [Abstract][Full Text] [Related]
22. No benefit of 3,4-diaminopyridine in essential tremor: a placebo-controlled crossover study.
Lorenz D; Hagen K; Ufer M; Cascorbi I; Deuschl G; Volkmann J
Neurology; 2006 Jun; 66(11):1753-5. PubMed ID: 16769957
[TBL] [Abstract][Full Text] [Related]
23. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome.
Smith-Hicks CL; Bridges DD; Paynter NP; Singer HS
Mov Disord; 2007 Sep; 22(12):1764-70. PubMed ID: 17566124
[TBL] [Abstract][Full Text] [Related]
24. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
Wasserman S; Iyengar R; Chaplin WF; Watner D; Waldoks SE; Anagnostou E; Soorya L; Hollander E
Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983
[TBL] [Abstract][Full Text] [Related]
25. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol.
Morita S; Miwa H; Kondo T
Parkinsonism Relat Disord; 2005 Mar; 11(2):101-3. PubMed ID: 15734668
[TBL] [Abstract][Full Text] [Related]
26. Zonisamide for essential tremor: an evaluator-blinded study.
Handforth A; Martin FC; Kang GA; Vanek Z
Mov Disord; 2009 Feb; 24(3):437-40. PubMed ID: 19117357
[TBL] [Abstract][Full Text] [Related]
27. Treatment of essential tremor with the barbiturate T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid).
Melmed C; Moros D; Rutman H
Mov Disord; 2007 Apr; 22(5):723-7. PubMed ID: 17265458
[TBL] [Abstract][Full Text] [Related]
28. Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.
Zhou B; Zhang Q; Tian L; Xiao J; Stefan H; Zhou D
Epilepsy Behav; 2008 Feb; 12(2):305-10. PubMed ID: 18024209
[TBL] [Abstract][Full Text] [Related]
29. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.
Gidal BE; Baltès E; Otoul C; Perucca E
Epilepsy Res; 2005; 64(1-2):1-11. PubMed ID: 15823510
[TBL] [Abstract][Full Text] [Related]
30. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
31. The anticonvulsant levetiracetam potentiates alcohol consumption in non-treatment seeking alcohol abusers.
Mitchell JM; Grossman LE; Coker AR; Messing RO
J Clin Psychopharmacol; 2012 Apr; 32(2):269-72. PubMed ID: 22367657
[TBL] [Abstract][Full Text] [Related]
32. Quantitative comparison of barbiturates in essential hand and head tremor.
Sasso E; Perucca E; Fava R; Calzetti S
Mov Disord; 1991; 6(1):65-8. PubMed ID: 2005924
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of piracetam in cortical myoclonus.
Brown P; Steiger MJ; Thompson PD; Rothwell JC; Day BL; Salama M; Waegemans T; Marsden CD
Mov Disord; 1993; 8(1):63-8. PubMed ID: 8419809
[TBL] [Abstract][Full Text] [Related]
34. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
[TBL] [Abstract][Full Text] [Related]
35. An open-label pilot study of levetiracetam for essential tremor.
Ondo WG; Jimenez JE; Vuong KD; Jankovic J
Clin Neuropharmacol; 2004; 27(6):274-7. PubMed ID: 15613931
[TBL] [Abstract][Full Text] [Related]
36. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
Wheless JW; Clarke D; Hovinga CA; Ellis M; Durmeier M; McGregor A; Perkins F
J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
[TBL] [Abstract][Full Text] [Related]
37. Levetiracetam monotherapy in children with epilepsy.
Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
[TBL] [Abstract][Full Text] [Related]
38. Effect of amantadine in essential tremor: a randomized, placebo-controlled trial.
Gironell A; Kulisevsky J; Pascual-Sedano B; Flamarich D
Mov Disord; 2006 Apr; 21(4):441-5. PubMed ID: 16229019
[TBL] [Abstract][Full Text] [Related]
39. Effect of a single oral dose of propranolol on essential tremor: a double-blind controlled study.
Calzetti S; Findley LJ; Gresty MA; Perucca E; Richens A
Ann Neurol; 1983 Feb; 13(2):165-71. PubMed ID: 6338809
[TBL] [Abstract][Full Text] [Related]
40. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus.
Uges JW; van Huizen MD; Engelsman J; Wilms EB; Touw DJ; Peeters E; Vecht CJ
Epilepsia; 2009 Mar; 50(3):415-21. PubMed ID: 19054418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]